Myonex ApS: Financial statements 2020
CVR: 39905094
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Myonex ApS (CVR 39905094) has filed annual accounts for 2020. In 2020, the company reported a gross profit of EUR -104,398 and a net result of EUR -104,968. Equity in the 2020 report amounted to EUR -178,512.
- Gross Profit
- EUR -104,398
- Profit/Loss
- EUR -104,968
- Equity
- EUR -178,512
- Total Assets
- EUR 3,677,509
Official annual report
How creditworthy is Myonex ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
On September 21, 2020, the company changed its name from Myoderm ApS to Myonex ApS.
Myonex ApS has published its interim report for the period September 28, 2018 to December 31, 2019.
About Myonex ApS
Myonex ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Myoderm ApS. The management consists of Gregory Thomas Lavin and Michael Allen Cohen. The company is owned by Myonex, LLC. In 2025, the company reported a gross profit of EUR 1,009,020 and a net result of EUR 580,466 compared with EUR 2,155,499 the year before. Equity in the 2025 report amounted to EUR 19,516,469.